Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2010
10/28/2010CA2756074A1 Fast-acting insulin formulation
10/27/2010EP2243495A1 A drug delivery system, its preparation process and use
10/27/2010EP2243490A1 Insulin nasal powder inhalation
10/27/2010EP2243487A1 Enteric coated formulation
10/27/2010EP2243484A2 Controlled release oxycodone compositions
10/27/2010EP2243477A1 Paracetamol for parenteral application
10/27/2010EP2243472A1 Freeze-dried agent compound
10/27/2010EP2243471A1 Matrix for sustained, invariant and independent release of active compounds
10/27/2010EP2242772A1 Immunoconjugates targeting cd138 and uses thereof
10/27/2010EP2242514A2 Intralymphatic chemotherapy drug carriers
10/27/2010EP2242505A2 Glycoconjugation of polypeptides using oligosaccharyltransferases
10/27/2010EP2242486A1 Encapsulation of vitamin c into water soluble dendrimers
10/27/2010EP2242485A2 Oral controlled release tablet
10/27/2010EP2242479A2 Counter-pressure filtration of proteins
10/27/2010EP2242476A2 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
10/27/2010EP2073850B1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
10/27/2010EP1830879B1 Mri guided photodynamic therapy for cancer
10/27/2010EP1567195B1 Dendrimer conjugates for selective solubilisation of protein aggregates
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1355674B1 Oligo alkylene glycol or polyalkylene glycol-coupled thrombin inhibitors
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP0681475B1 Therapeutic inhibitors of vascular smooth muscle cells
10/27/2010CN201612864U 壳聚糖包覆药物缓释微球 Chitosan microspheres coated drug delivery
10/27/2010CN1662930B Actuation indicator for a dispensing device
10/27/2010CN1649568B Pharmaceutical compositions for the treatment of asthma
10/27/2010CN1617742B Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist
10/27/2010CN101873861A Composition for preventing virus infection comprising poly-gamma-glutamic acid
10/27/2010CN101873859A Transdermally absorptive preparation
10/27/2010CN101873848A Tablettable formulations of lipophilic health ingredients
10/27/2010CN101870769A PEG (Polyethylene Glycol), mPEG (Methoxy Polyethylene Glycol) chemical modifier and method thereof for preparing water-soluble resveratrol prodrug
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101870767A Preparation method of pegylated 1,2-bialiphatic acyl phosphatidylethanolamine
10/27/2010CN101870755A Glutinous rice starch/acrylic ester interpolymer and composite and application thereof
10/27/2010CN101870738A Alkyl acid esterified glutinous rice flour and preparation method as well as application thereof
10/27/2010CN101870735A Novel high-glycosylation erythropoietin immune fusion protein
10/27/2010CN101870728A Novel Exendin variant and conjugate thereof
10/27/2010CN101870726A Peptide - cisplatin conjugate and preparation method and application thereof
10/27/2010CN101870719A Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869713A Active agent delivery systems and methods for protecting and administering active agents
10/27/2010CN101869712A Medicinal composition used for treating tumor by utilizing polymeric micelles of cyst anticancer drugs
10/27/2010CN101869704A Single dose immunization against tetanus toxin cation dextran microspheres and preparation method thereof
10/27/2010CN101869699A Preparation process of bone peptide soft capsule
10/27/2010CN101869668A Film coating agent for treating empyrosis and preparation method thereof
10/27/2010CN101869633A Enteric-coated medicament combination containing epigallocatechin gallate
10/27/2010CN101869570A Ciclesonide contained pharmaceutical composition for application to mucosa
10/27/2010CN101869569A Ready-to-use entecavir composite
10/27/2010CN101869561A Tacrolimus-containing improved release composition
10/27/2010CN101869555A Nifedipine controlled -release tablet and preparation technology thereof
10/27/2010CN101869554A Doxazosin mesylate controlled release tablet and preparation technology thereof
10/27/2010CN101869553A Bupropion hydrochloride sustained release tablets and preparation method thereof
10/27/2010CN101869552A Preparation method of chitin tablet
10/27/2010CN101869551A Temozolomide freeze-dried preparation
10/27/2010CN101869550A Oral sustained-release dry suspension taking clarithromycin as main ingredient
10/27/2010CN101869549A Oral sustained-release dry suspension taking roxithromycin as main ingredient
10/27/2010CN101869548A Oral sustained-release dry suspension taking azithromycin as main ingredient
10/27/2010CN101869547A Tacrolimus injection preparation
10/27/2010CN101869546A Supermolecular gel used for protecting photostability of vitamin A derivatives
10/27/2010CN101869545A Preparation method of embedded drug-loaded glucomannan and xanthan gum composite gel
10/27/2010CN101869544A Ambroxol hydrochloride controlled release suspension and preparation method thereof
10/27/2010CN101574328B Timing pulsed release micro-pill of zolpidem salt
10/27/2010CN101518513B Cinepazide maleate lipid microspheres preparation and preparation method thereof
10/27/2010CN101444508B Tropisetron preparation for injection and preparation method thereof
10/27/2010CN101264087B Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof
10/27/2010CN101249261B Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
10/27/2010CN101239996B Method for preparing high shearing force microcrystal lactose
10/27/2010CN101229172B Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
10/27/2010CN101209171B Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof
10/27/2010CN101181232B Marseilledinun sustained-release implantation agent for curing entity tumour
10/27/2010CN101081215B Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof
10/27/2010CN101028521B Oral colon positioning feed preparation based on electric spinning superfine nuclear fibre and its making method
10/26/2010US7820788 injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis
10/26/2010US7820766 Branched acetylene-containing poly(alkylene oxides, oxyethylated polyols or olefinic alcohols)
10/26/2010US7820759 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820639 glycerol, dextran, chondroitin sulfate, water, and buffer; for treating corneal edema, for accompanying corneal transplantation and refractive corneal surgery
10/26/2010US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
10/26/2010US7820594 agricultural fungicide or herbicide; fatty acids with another synergistic organic acid; emulsifierl; amino acid
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820390 Methods of and kits and compositions for diagnosing colorectal tumors
10/26/2010US7820211 Cosmetic material containing sweet pea extract
10/26/2010US7820204 Drug delivery system targeting to estrogen receptor over-expressed cells
10/26/2010US7820201 controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles zero-order release profiles, escalating release profiles or decreasing release profiles. The dosage forms of the present invention can include spatial variation of API dosage forms
10/26/2010US7820199 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine
10/26/2010US7820197 Using bisphosphonic acid compound; mixture with solubilizer; permeability through skin
10/26/2010US7820196 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010US7820158 Ligand-coupled initiator polymers and methods of use
10/26/2010US7819796 Embryo modification and implantation
10/26/2010CA2661573C Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
10/26/2010CA2498267C Method for treating erectile dysfunction and increasing libido in men
10/26/2010CA2487270C Antimicrobial compositions, products and methods employing same
10/26/2010CA2457780C Topical compositions and methods for treating pain
10/26/2010CA2454449C Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form
10/26/2010CA2418921C Novel composition
10/26/2010CA2418862C Antioxidants in clusters of structured water
10/26/2010CA2418316C Process for producing mouldings from (meth)acrylate copolymers by means of injection moulding
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds